Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02631577
Title A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
University Miami Miami Florida 33136 United States Details
Norton Medical Plaza II Louisville Kentucky 40207 United States Details
Memorial Sloan-Kettering Cancer Center; Hematology/Oncology New York New York 10065 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Chu Toulouse Bron 69500 France Details
Hopital Henri Mondor; 51 Av Mal Lattre De Tassigny Creteil 94010 France Details
Hopital du Bocage Dijon 21034 France Details
Centre Jean Bernard Le Mans 72015 France Details
Centre Hospitalier Le Mans Le Mans 72037 France Details
CHRU de Lille - Hopital Claude Huriez Lille 59037 France Details
CHU Montpellier - Saint ELOI Montpellier 34295 France Details
CHU - Hôtel Dieu hematolgie clinique Nantes 44093 France Details
Centre Hospitalier Lyon Sud; Hematolgie Pierre Benite 69495 France Details
CHU de Rennes - Hopital de Pontchaillo Rennes 35033 France Details
Centre Henri Becquerel Rouen 76038 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field